Women across the U.S. are now pursuing product liability lawsuits and medical monitoring class action claims to secure compensation for potential brain tumor symptoms and side effects linked to the use of Depo-Provera.
The judge presiding over the federal Valsartan lawsuits has been asked to approve the creation of a qualified settlement fund, as well as appoint an administrator and custodian for funds that will be paid to former users of the recalled hypertension drugs who have developed cancer.
A federal judge has set the first two dates for BioZorb lawsuit bellwether trials, with the first claims slated to go before juries Sept. 8, 2025 and Jan. 20, 2026.
